LETTER
Where's the Bias?
Jack M. Gwaltney, Jr., MD
1 January 1998 | Volume 128 Issue 1 | Page 75
TO THE EDITOR:
The answer to the question posed in Dr. Davidoff's editorial, "Where's the bias?" [1], which concerned the study by Mossad and colleagues [2] on zinc lozenge treatment of the common cold, is that there is reason to believe that the participants were not properly blinded because of a faulty placebo. The reasons for this conclusion were carefully outlined in a previous letter to Annals [3]. That letter should not be dismissed as providing "little criticism" to the scientific quality of the study. Inadequate blinding, if present, is a serious fault in a clinical trial in which effective blinding is a necessary component of the experimental design. Other problems with the design of the study were discussed in the previous letter.
I agree with Dr. Davidoff's answer-"Of course not"-to his rhetorical question, "Does the study in question prove the efficacy of zinc in controlling the symptoms of the common cold?"
|
Author and Article Information
|
|---|
University of Virginia Health Sciences Center; Charlottesville, VA 22908
1. Davidoff F. Where's the bias? [Editorial] Ann Intern Med. 1997; 126:986-8.
2. Mossad SB, Macknin ML, Medendorp SV, Mason P. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study. Ann Intern Med. 1996; 125:81-8.
3. Farr BM, Hayden FG, Gwaltney J Jr. Zinc gluconate lozenges for treating the common cold [Letter]. Ann Intern Med. 1997; 126:738.
About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
Include no more than 300 words of text, three authors, and five references
Type with double-spacing
Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.